
What We're Reading: Prevalence of Underlying Conditions; Opioid Label Change; ICE Detainees Held
New CDC data outline the prevalence of 5 common underlying health conditions that exacerbate coronavirus disease 2019 (COVID-19) symptoms; the FDA announced information regarding naloxone must be included on labels for opioids and opioid use disorder medications; despite a district judge's ruling nearly a month ago, hundreds of migrant detainees are being held in detention centers in states where COVID-19 cases are surging.
Data Highlight Prevalence of Underlying Health Conditions
Nearly 50% of American adults live with an underlying medical condition, strongly tied to severe coronavirus disease 2019 (COVID-19) outcomes, CIDRAP
Naloxone Information Required on Opioid Medication Labels
The FDA
Migrant Detainees Held in Facilities During COVID-19 Surge
Despite a judge’s order mandating their release, nearly 350 migrant parents and children remain in Immigration and Customs Enforcement (ICE) facilities with coronavirus outbreaks, The Hill
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.